Newsletter

Int. Rev. Allergol. Clin. Immunol. Family Med., 2016, XXII/1: 044-048 Maximize

Int. Rev. Allergol. Clin. Immunol. Family Med., 2016, XXII/1: 044-048

Title: Lung function abnormalities in sarcoidosis 

Author: Przybyłowska K. 

More details

07-01-2016

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Lung function abnormalities in sarcoidosis

Przybyłowska K.

EMC Medical Institute SA – Department of Internal Medicine and Lung Disease, Hospital st. Anna in Piaseczno, Poland

Int Rev Allergol Clin Immunol Family Med, 2016; Vol. 22, No. 1, 044

Sarcoidosis is a granulomatous disease of unknown etiology with enlarged hilar and mediastinal lymph nodes, nodular pulmonary and extrapulmonary involvement as the most important clinical features. Lung function testing is a key element for diagnosis and monitoring in sarcoidosis. The frequency of functional abnormalities increase with disease progression. Airway obstruction, restrictive pattern, bronchial hyperreactivity, decreased diffusing lung capacity for carbon monoxide, decreased respiratory muscle strength and physical exercise capacity are listed as the most frequently encountered functional abnormalities in sarcoidosis. Forced vital capacity (FVC) is the WASOG recommended variable for disease activity monitoring.

Key words: sarcoidosis, pulmonary function tests, forced vital capacity